Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSJ137 in functional iron-deficiency anemia
NCT02570854Phase 1Completed
- Sponsor
- Novartis
- Start
- Sep 2015
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 1, randomised, double-blind trial in iron deficiency anemia (IDA) comparing CSJ137 with Placebo (2 arms). Primary endpoints: Number of participants with treatment-related adverse events and Minimum active dose of CSJ137. Started Sep 2015; status: completed.
02
Drugs
CSJ137
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT02570854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02570854.